查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1809946

精准诊断和精准医疗市场（按产品、技术、应用和最终用户划分）—全球预测，2025-2030 年

Precision Diagnostics & Medicine Market by Product, Technology, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

精准诊断与精准医疗市场规模预计在2024年达到1405.7亿美元，2025年增长至1551.4亿美元，复合年增长率为11.00%，2030年达到2629.6亿美元。

主要市场统计数据
基准年2024年 1405.7亿美元
预计2025年 1551.4亿美元
预测年份 2030 2629.6亿美元
复合年增长率（%） 11.00%

探索精准诊断和精准医疗的不断发展，将数据主导的洞察力与治疗创新相结合，以获得策略优势

在基因组学、分子生物学和数位健康分析领域的突破下，精准诊断和精准医疗领域正在经历显着变革。随着定序技术日益普及，运算能力不断提升，医疗保健相关人员正在利用数据主导的洞察，提供标靶治疗，改善患者预后。本介绍将帮助您理解这些融合趋势如何重新定义诊断，实现更早的疾病检测，并促进个人化治疗途径。

透过人工智慧突破、监管变革和以患者为中心的治疗创新，确定再形成精准诊断和精准医疗的关键转型转变

近年来，一系列变革性变化重塑了精准诊断和精准医疗生态系统。人工智慧和机器学习已成为关键推动因素，它们释放更深层的分子数据，为预测模型提供讯息，并加速生物标誌物的发现。同时，次世代定序平台的成熟显着缩短了周转时间，使临床决策更加及时，并支持快速识别可操作的基因变异。

评估2025年实施的美国关税对精准诊断和精准医疗供应链、定价和全球伙伴关係的累积影响

2025年美国关税的实施，为精准诊断和精准医疗领域的相关人员带来了新的考量。关键试剂、定序设备和实验室耗材的进口关税导致学术和商业实验室的采购成本上升。这种关税环境促使企业重新评估其全球供应链，并寻求近岸外包策略，以降低贸易中断风险，同时确保关键材料的可靠供应。

全面的市场理解，包括按产品、技术、应用和最终用户分類的关键细分洞察

深入了解市场区隔对于确定成长路径和优化资源配置至关重要。在产品领域，抗病毒药物在对抗感染疾病继续发挥关键作用，而细胞和基因疗法则推动了个人化介入的前沿发展。抑制剂针对关键的分子通路，单株抗体则提供高度特异性的治疗方法，每个细分市场都展现出独特的发展路径和商业化动态。

来自美洲、欧洲、中东和非洲以及亚太地区的关键见解，揭示战略机会、挑战和成长催化剂

区域因素在精准诊断和精准医疗的采用和可近性方面发挥关键作用。在美洲，强大的研究基础设施和积极的医疗政策促进了基因组定序和基于价值的医疗模式的早期应用。学术中心和商业公司之间的合作正在加速将研究成果转化为临床实践，监管机构也强调加快审查程序以支持患者获取相关服务。

透过策略伙伴关係、产品线创新和市场领导策略塑造精准诊断和精准医疗生态系统的知名公司简介

精准诊断和精准医疗领域的竞争态势正受到成熟生命科学集团与新兴技术创新者融合的影响。领先的开发商正在利用策略伙伴关係关係，整合各自在检测方法开发、生物标记发现和临床检验方面的优势，共同开发一体化的诊断和治疗解决方案。这些联盟通常会发展成为共同商业化协议，从而加快市场渗透速度并共用管理风险。

为行业领导者提供可行的建议，以应对不断变化的市场动态、优化创新并加强其在精准医疗领域的竞争地位

为了因应瞬息万变的精准诊断和精准医疗格局，产业领导者应优先整合人工智慧工具，以增强数据解读能力、加速生物标记发现并优化临床试验设计。同时，透过建立区域製造中心来实现供应链网络多元化，可以减轻关税的影响，并提高对贸易政策变化的抵御能力。采用基于价值的医疗框架并展示临床效用的真实证据，对于确保报销和推动医生采用至关重要。

概述所采用的综合调查方法，包括主要和次要资料收集、分析框架和检验通讯协定，以确保报告的完整性

本报告采用严谨的调查方法，整合一手资料和二手资料，确保分析的深度与准确性。一手资料研究包括对高阶主管、临床研究人员和监管专家的深入访谈，以深入观点创新趋势、应用障碍和策略重点。同时进行的二手资料研究则利用同行评审文献、公司出版物和政府政策文件，为研究结果提供背景资讯并检验市场发展。

对精准诊断和精准医疗趋势的结论性见解和策略意义，为相关人员的决策提供资讯并增强市场准备

技术进步、监管动力和病患主导需求的融合，凸显了精准诊断和精准医疗的变革时期。透过分析，我们揭示了关键的主题要务，包括面对不断变化的贸易政策，需要建立敏捷的供应链，细分重点的策略协调，以及区域方法的必要事项。总而言之，这些见解为组织提供了一条利用创新、管理风险和产生临床影响的前进之路。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章市场动态

  • 整合人工智慧驱动的多组体学分析，实现个人化癌症治疗选择
  • 扩展液态生物检体平台以实现早期疾病检测和监测
  • 采用基于 CRISPR 的诊断技术进行快速即时基因检测
  • 开发数位双胞胎模型以优化个人化药物管理策略
  • 奈米孔定序在即时感染疾病监测的应用日益广泛
  • 引入远端医疗支援的居家生物标记检测，用于慢性病管理
  • 放射基因组学中新兴的人工智慧演算法可预测肿瘤行为和治疗反应
  • 自体自体免疫疾病综合生物标记组合的多重免疫检测进展
  • 监管协调加速标靶治疗伴随诊断的全球核准
  • 製药和科技公司合作开发穿戴式生物感测器，用于持续健康监测

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第八章精准诊断和精准医疗市场（按产品）

  • 抗病毒药物
  • 细胞治疗和基因治疗
  • 抑制剂
  • 单株抗体

第九章 精准诊断与精准医疗市场（按技术）

  • 基因组学
  • 分子诊断
    • 次世代定序
    • PCR
  • 蛋白质体学

第 10 章精准诊断与精准医疗市场（按应用）

  • 疾病诊断
    • 慢性病
    • 遗传性疾病
  • 精准治疗
    • 个人化医疗
    • 标靶治疗
  • 研究与开发

第11章精准诊断与精准医疗市场（依最终用户）

  • 临床实验室
    • 诊断实验室
    • 研究实验室
  • 医院

第 12 章：美洲精准诊断与精准医疗市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第 13 章：欧洲、中东和非洲的精准诊断与精准医疗市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

14. 亚太地区精准诊断与精准医疗市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • AstraZeneca PLC
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • Biogen Inc.
    • Bristol-Myers Squibb Company
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd
    • GE Healthcare Technologies, Inc.
    • Illumina, Inc.
    • International Business Machines Corp.
    • Johnson & Johnson Services, Inc.
    • Koninklijke Philips NV
    • Lantheus Medical Imaging, Inc.
    • Medtronic PLC
    • Myriad Genetics Inc.
    • Novartis AG
    • OneOme, LLC
    • Pfizer Inc.
    • Qiagen NV
    • Quest Diagnostics Incorporated
    • Sanofi SA
    • Siemens Healthineers
    • Swiss Precision Diagnostics GmbH
    • Thermo Fisher Scientific Inc.

第十六章 研究人工智慧

第十七章 研究统计

第十八章 研究联络人

第十九章 研究报导

第二十章 附录

Product Code: MRR-50750BF5CD44

The Precision Diagnostics & Medicine Market was valued at USD 140.57 billion in 2024 and is projected to grow to USD 155.14 billion in 2025, with a CAGR of 11.00%, reaching USD 262.96 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 140.57 billion
Estimated Year [2025] USD 155.14 billion
Forecast Year [2030] USD 262.96 billion
CAGR (%) 11.00%

Exploring the evolving landscape of precision diagnostics and medicine where data-driven insights converge with therapeutic innovation for strategic advantage

The landscape of precision diagnostics and medicine has undergone a remarkable evolution, propelled by breakthroughs in genomics, molecular biology, and digital health analytics. As sequencing technologies become more accessible and computational power continues to grow, stakeholders across the healthcare spectrum are harnessing data-driven insights to deliver targeted therapies and improve patient outcomes. This introduction sets the stage for understanding how converging trends are redefining diagnostics, enabling early disease detection, and facilitating personalized treatment pathways.

Moreover, regulatory bodies have increasingly embraced adaptive approval pathways and novel reimbursement models to support innovation in this sector. Public-private partnerships are fostering collaborative ecosystems that expedite clinical validation and streamline commercialization. Concurrently, heightened patient awareness and advocacy are driving demand for tailored diagnostic solutions, compelling industry participants to refine precision medicine strategies. Against this dynamic backdrop, an integrated perspective on emerging technological, regulatory, and patient-centric forces is essential for charting a strategic course in precision diagnostics and medicine.

Identifying pivotal transformative shifts reshaping precision diagnostics and medicine driven by AI breakthroughs, evolving regulations, and patient-centric care innovations

In recent years, a series of transformative shifts have reshaped the precision diagnostics and medicine ecosystem. Artificial intelligence and machine learning have emerged as critical enablers, unlocking deeper layers of molecular data to inform predictive models and accelerate biomarker discovery. At the same time, the maturation of next-generation sequencing platforms has significantly reduced turnaround times, enabling more timely clinical decision-making and supporting the rapid identification of actionable genetic variants.

In parallel, regulatory agencies have introduced more flexible frameworks to manage breakthrough designations and real-world evidence generation. This regulatory realignment has encouraged cross-sector collaborations, uniting biopharmaceutical companies, diagnostic innovators, and healthcare providers in co-development initiatives. Patients are now at the center of care models, exerting influence through direct-to-consumer testing and personalized health tracking. Consequently, industry participants must navigate an environment where technological prowess, regulatory agility, and patient engagement converge to define competitive success.

Evaluating the cumulative impact of the United States tariffs introduced in 2025 on the precision diagnostics and medicine supply chain, pricing, and global collaborations

The implementation of the United States tariffs in 2025 has introduced new considerations for stakeholders in precision diagnostics and medicine. Import duties on key reagents, sequencing instruments, and laboratory consumables have contributed to elevated procurement costs for academic and commercial laboratories alike. This tariff environment has prompted companies to reevaluate global supply chains, exploring nearshoring strategies to mitigate exposure to trade disruptions while ensuring reliable access to critical materials.

In addition, the elevated cost base has spurred increased collaboration with domestic manufacturers and accelerated investments in localized production facilities. As a result, suppliers are adapting their pricing models and exploring alternative sourcing partnerships to maintain competitive margins. Furthermore, the tariffs have underscored the importance of diversified supplier networks and the strategic integration of tariff impact assessments into long-term planning. Organizations that proactively incorporate these elements into their operational frameworks are better positioned to sustain innovation momentum and preserve market access amid shifting trade policies.

Deriving key segmentation insights across product categories, technology platforms, application domains, and end-user environments for comprehensive market understanding

A nuanced understanding of market segmentation is essential for identifying growth corridors and optimizing resource allocation. Within the realm of product offerings, antiviral drugs continue to play a vital role in combating infectious diseases, while cell and gene therapies are advancing the frontier of personalized interventions. Inhibitor drugs target critical molecular pathways, and monoclonal antibodies offer highly specific therapeutic modalities, each segment presenting unique development pathways and commercialization dynamics.

Technology platforms further refine strategic focus, with genomics driving the discovery of genetic variants, molecular diagnostics-spanning next-generation sequencing and polymerase chain reaction-delivering precise molecular profiles, and proteomics elucidating protein interactions and post-translational modifications. Application domains range from disease diagnosis, covering chronic conditions and genetic disorders, to precision therapeutics encompassing personalized medicine and targeted therapies, as well as research and development activities that fuel ongoing innovation. Finally, end-user dynamics influence adoption patterns, as clinical laboratories-both diagnostic and research-and hospitals integrate these solutions into care pathways. By dissecting these layers, organizations can tailor their strategies to align with segment-specific drivers and customer needs.

Interpreting key regional insights across Americas, Europe Middle East Africa, and Asia Pacific highlighting strategic opportunities, challenges, and growth catalysts

Regional considerations play a pivotal role in shaping the adoption and accessibility of precision diagnostics and medicine. In the Americas, robust research infrastructure and proactive health policies have facilitated early uptake of genomic sequencing and value-based care models. Collaboration between academic centers and commercial entities has accelerated the translation of discoveries into clinical practice, while regulatory bodies emphasize expedited review pathways to support patient access.

Across Europe, the Middle East, and Africa, evolving regulatory harmonization efforts are streamlining cross-border clinical trials and encouraging harmonized standards for diagnostics. Public health initiatives in emerging markets are investing in capacity building for molecular testing to address population health challenges. Meanwhile, achieving equitable access remains a priority, driving collaborations between governments, non-profit organizations, and industry partners.

In the Asia-Pacific region, significant investments in biotechnology infrastructure and life sciences research are fueling rapid expansion. Governments are implementing favorable reimbursement schemes to support precision therapeutics, and a growing network of diagnostic laboratories is enhancing capacity for high-throughput sequencing. As a result, industry participants must tailor regional entry strategies to accommodate diverse regulatory landscapes, reimbursement frameworks, and local innovation ecosystems.

Profiling prominent companies shaping the precision diagnostics and medicine ecosystem through strategic partnerships, pipeline innovation, and market leadership strategies

Competitive dynamics in precision diagnostics and medicine are shaped by a blend of established life sciences conglomerates and emerging technology innovators. Leading organizations are leveraging strategic partnerships to co-develop integrated diagnostic-therapeutic solutions, combining strengths in assay development, biomarker discovery, and clinical validation. These alliances often extend into co-marketing agreements, enabling faster market penetration and shared risk management.

Investment in research and development remains a cornerstone of differentiation, with companies channeling resources into proprietary platforms, novel biomarker pipelines, and advanced analytical tools. Mergers and acquisitions have also intensified as global players seek to consolidate capabilities in genomics, proteomics, and companion diagnostics. In parallel, smaller specialist firms are capitalizing on niche expertise by offering modular, cloud-enabled solutions that streamline laboratory workflows and enhance data interpretation.

Intellectual property strategies continue to influence competitive positioning, with patent portfolios securing market exclusivity for breakthrough innovations. As a result, organizations that successfully integrate cross-disciplinary assets and sustain a balanced pipeline of near-term and long-term projects are best positioned to drive leadership in the rapidly evolving precision medicine ecosystem.

Articulating actionable recommendations for industry leaders to navigate evolving market dynamics, optimize innovations, and strengthen competitive positioning in precision medicine

To navigate the dynamic precision diagnostics and medicine landscape, industry leaders should prioritize the integration of artificial intelligence tools to enhance data interpretation, accelerate biomarker discovery, and optimize clinical trial design. Simultaneously, diversifying supply chain networks by establishing regional manufacturing hubs will reduce tariff exposure and improve resilience against trade policy shifts. Embracing value-based care frameworks and demonstrating real-world evidence of clinical utility will be critical for securing reimbursement and driving physician adoption.

Moreover, organizations should foster collaborative ecosystems by engaging with academic institutions, patient advocacy groups, and regulatory authorities to co-create standards for diagnostic validation and personalized therapeutic pathways. Investing in workforce development initiatives will ensure that laboratory personnel and clinicians are equipped to leverage advanced platforms effectively. Finally, cultivating flexible commercialization strategies that adapt to regional regulatory landscapes and healthcare infrastructure variability will enable sustainable growth and global market reach.

Outlining the comprehensive research methodology employed including primary and secondary data collection, analytical frameworks, and validation protocols for report integrity

This report is underpinned by a rigorous research methodology that synthesizes primary and secondary sources to ensure analytical depth and accuracy. Primary research included in-depth interviews with senior executives, clinical researchers, and regulatory experts to capture frontline perspectives on innovation trends, adoption barriers, and strategic priorities. In parallel, secondary research leveraged peer-reviewed literature, company publications, and governmental policy documents to contextualize findings and validate market developments.

Analytical frameworks such as SWOT and PESTEL were employed to systematically evaluate macroeconomic drivers, regulatory shifts, and technological disruptions. Data triangulation techniques were applied to reconcile disparate information sources and enhance confidence in the conclusions drawn. Furthermore, validation protocols involved cross-functional review sessions with industry specialists to refine insights and ensure relevance to diverse stakeholder needs. This comprehensive approach provides a robust foundation for informed decision-making and strategic planning in the precision diagnostics and medicine sector.

Summarizing conclusive insights and strategic implications of precision diagnostics and medicine trends to inform stakeholder decision-making and boost market readiness

The convergence of technological advancements, regulatory momentum, and patient-driven demand underscores a transformative era for precision diagnostics and medicine. Throughout this analysis, key thematic imperatives have emerged: the necessity of agile supply chains in the face of trade policy shifts, the strategic alignment of segmentation priorities, and the tailored adaptation of regional approaches. Collectively, these insights illuminate pathways for organizations to harness innovation, manage risk, and deliver clinical impact.

As industry participants continue to refine their strategies, maintaining a holistic perspective on technological ecosystems, stakeholder collaborations, and emerging policy landscapes will be paramount. By integrating the actionable recommendations and segmentation insights presented herein, decision-makers can confidently navigate complexity, catalyze growth, and ultimately improve patient outcomes. This conclusive synthesis serves as a strategic compass for stakeholders seeking to lead in the dynamic realm of precision diagnostics and medicine.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of AI-driven multi-omics profiling for personalized cancer therapy selection
  • 5.2. Expansion of liquid biopsy platforms enabling early disease detection and monitoring
  • 5.3. Adoption of CRISPR-based diagnostics for rapid point-of-care genetic testing
  • 5.4. Development of digital twin models to optimize individualized drug dosing strategies
  • 5.5. Growth of nanopore sequencing applications in real-time infectious disease surveillance
  • 5.6. Implementation of telehealth-enabled at-home biomarker testing for chronic disease management
  • 5.7. Emergence of AI algorithms in radiogenomics to predict tumor behavior and therapy response
  • 5.8. Advancement of multiplexed immunoassays for comprehensive biomarker panels in autoimmune disorders
  • 5.9. Regulatory harmonization accelerating global approval of companion diagnostics for targeted therapies
  • 5.10. Collaboration between pharma and tech companies on wearable biosensors for continuous health monitoring

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Precision Diagnostics & Medicine Market, by Product

  • 8.1. Introduction
  • 8.2. Antiviral Drugs
  • 8.3. Cell & Gene Therapies
  • 8.4. Inhibitor Drugs
  • 8.5. Monoclonal Antibodies

9. Precision Diagnostics & Medicine Market, by Technology

  • 9.1. Introduction
  • 9.2. Genomics
  • 9.3. Molecular Diagnostics
    • 9.3.1. Next-Generation Sequencing
    • 9.3.2. Polymerase Chain Reaction
  • 9.4. Proteomics

10. Precision Diagnostics & Medicine Market, by Application

  • 10.1. Introduction
  • 10.2. Disease Diagnosis
    • 10.2.1. Chronic Diseases
    • 10.2.2. Genetic Disorders
  • 10.3. Precision Therapeutics
    • 10.3.1. Personalized Medicine
    • 10.3.2. Targeted Therapies
  • 10.4. Research & Development

11. Precision Diagnostics & Medicine Market, by End User

  • 11.1. Introduction
  • 11.2. Clinical Laboratories
    • 11.2.1. Diagnostic Laboratories
    • 11.2.2. Research Laboratories
  • 11.3. Hospitals

12. Americas Precision Diagnostics & Medicine Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Precision Diagnostics & Medicine Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Precision Diagnostics & Medicine Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Abbott Laboratories
    • 15.3.2. AstraZeneca PLC
    • 15.3.3. Baxter International Inc.
    • 15.3.4. Becton, Dickinson and Company
    • 15.3.5. Biogen Inc.
    • 15.3.6. Bristol-Myers Squibb Company
    • 15.3.7. Danaher Corporation
    • 15.3.8. F. Hoffmann-La Roche Ltd
    • 15.3.9. GE Healthcare Technologies, Inc.
    • 15.3.10. Illumina, Inc.
    • 15.3.11. International Business Machines Corp.
    • 15.3.12. Johnson & Johnson Services, Inc.
    • 15.3.13. Koninklijke Philips N.V.
    • 15.3.14. Lantheus Medical Imaging, Inc.
    • 15.3.15. Medtronic PLC
    • 15.3.16. Myriad Genetics Inc.
    • 15.3.17. Novartis AG
    • 15.3.18. OneOme, LLC
    • 15.3.19. Pfizer Inc.
    • 15.3.20. Qiagen NV
    • 15.3.21. Quest Diagnostics Incorporated
    • 15.3.22. Sanofi S.A.
    • 15.3.23. Siemens Healthineers
    • 15.3.24. Swiss Precision Diagnostics GmbH
    • 15.3.25. Thermo Fisher Scientific Inc.

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. PRECISION DIAGNOSTICS & MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. PRECISION DIAGNOSTICS & MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. PRECISION DIAGNOSTICS & MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. PRECISION DIAGNOSTICS & MEDICINE MARKET: RESEARCHAI
  • FIGURE 24. PRECISION DIAGNOSTICS & MEDICINE MARKET: RESEARCHSTATISTICS
  • FIGURE 25. PRECISION DIAGNOSTICS & MEDICINE MARKET: RESEARCHCONTACTS
  • FIGURE 26. PRECISION DIAGNOSTICS & MEDICINE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. PRECISION DIAGNOSTICS & MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY ANTIVIRAL DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY ANTIVIRAL DRUGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CELL & GENE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CELL & GENE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INHIBITOR DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INHIBITOR DRUGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY GENOMICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PROTEOMICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TARGETED THERAPIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TARGETED THERAPIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 66. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 67. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 69. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 71. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 73. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 75. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 76. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 77. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 79. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 80. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 81. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 83. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 84. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 85. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 86. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 87. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 88. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 89. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 90. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 91. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 92. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 93. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 94. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 95. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 96. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 97. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 98. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 99. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 100. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 101. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 102. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 103. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 104. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 105. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 106. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 107. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 109. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 110. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 111. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 112. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 113. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 115. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 116. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 117. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 118. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 119. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 120. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 121. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 122. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 123. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 125. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 126. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 127. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 128. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 129. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 131. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 132. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 133. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 134. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 135. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 136. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 137. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 138. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 139. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 141. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 142. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 143. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 144. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 145. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 147. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 148. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 149. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 150. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 151. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 153. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 154. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 155. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 157. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 158. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 159. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 160. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 161. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 163. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 164. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 184. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 192. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 194. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 198. UNITED KINGDOM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 199. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 200. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 201. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 202. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 203. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 204. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 205. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 207. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 208. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 209. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 210. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 211. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 213. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 214. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 215. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 216. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 217. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 219. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 220. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 221. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 223. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 224. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 225. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 226. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 227. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 229. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 230. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 231. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 232. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 233. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 235. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 236. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 237. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 239. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 240. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 241. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 242. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 243. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 245. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 246. RUSSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 247. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 248. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 249. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 251. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 252. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 253. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 255. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 256. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 257. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 258. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 259. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 261. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 262. ITALY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 263. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 264. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 265. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 267. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 268. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 269. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 271. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 272. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 273. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 274. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 275. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 277. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 278. SPAIN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2025-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 287. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
  • TABLE 288. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
  • TABLE 289. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2024 (USD MILLION)
  • TABLE 290. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2025-2030 (USD MILLION)
  • TABLE 291. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 293. UNITED ARAB EMIRATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 294. UNITED ARAB EMIRAT